Non-Hodgkin's Lymphoma (NHL) Clinical Trial
Official title:
The Safety and Efficacy Assessment of Ex-Vivo Expanded Allogeneic γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) and Peripheral T Cell Lymphomas (PTCL)
This study aims to evaluate the safety, tolerability and efficacy of ex-vivo expanded allogeneic γδT cells obtained from a blood-related donor of patients with relapsed or refractory B cell non-Hodgkin's lymphoma (B-NHL) or peripheral T cell lymphoma (PTCL) expect for γδT lymphoma.
This study is a single-center, non-randomized, open label, no control, prospective clinical trial to evaluate the safety, tolerability and efficacy of ex-vivo expanded allogeneic γδT cells from a blood-related donor of NHL or PTCL patients(except for γδT lymphoma). This study will include the following sequential phases: sign informed consent, γδT cell pre-culture, screening and registration to the trial, apheresis, γδT cell preparation, pre-treatment for lymphodepleting chemotherapy (selectable plan), treatments and follow-ups. The study will evaluate the safety and efficacy of the ex-vivo expanded allogeneic γδT cells in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) or peripheral T cell lymphoma (PTCL) expect for γδT lymphoma. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01448928 -
Zevalin Post-marketing Surveillance in Japan
|
||
| Terminated |
NCT00089284 -
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
|
Phase 1/Phase 2 | |
| Unknown status |
NCT01983761 -
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01758042 -
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
|
N/A | |
| Terminated |
NCT00185679 -
Haploid Allogeneic Transplant Using the CliniMACS System
|
Phase 2 | |
| Completed |
NCT01108341 -
Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
|
Phase 2 | |
| Completed |
NCT00129090 -
Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma
|
Phase 3 | |
| Completed |
NCT01527838 -
Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit
|
Phase 1 | |
| Completed |
NCT00923910 -
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
|
Phase 1/Phase 2 | |
| Completed |
NCT00614042 -
Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Completed |
NCT02071888 -
Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors
|
Phase 1 | |
| Completed |
NCT01479387 -
Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan
|
N/A | |
| Completed |
NCT00889798 -
Tumor Registry of Lymphatic Neoplasia
|
||
| Terminated |
NCT05144347 -
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
|
Phase 1 |